Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade A 79.94 -0.03% -0.02
ABT closed down 0.03 percent on Wednesday, March 20, 2019, on 87 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABT trend table...

Date Alert Name Type % Chg
Mar 20 Bollinger Band Squeeze Range Contraction 0.00%
Mar 20 New 52 Week High Strength 0.00%
Mar 20 Multiple of Ten Bearish Other 0.00%
Mar 20 Overbought Stochastic Strength 0.00%
Mar 19 MACD Bullish Signal Line Cross Bullish -0.03%
Mar 19 New 52 Week Closing High Bullish -0.03%
Mar 19 Bollinger Band Squeeze Range Contraction -0.03%
Mar 19 New 52 Week High Strength -0.03%
Mar 19 Multiple of Ten Bearish Other -0.03%
Mar 19 Overbought Stochastic Strength -0.03%

Older signals for ABT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Medicine Cancer Life Sciences Pain Diabetes Illinois Inflammation Influenza Hypertension Health Care Products Irritable Bowel Syndrome Cataract Dyslipidemia Fever Vascular Disease Cataract Surgery Generic Pharmaceuticals Data Management Software Hypothyroidism
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 80.43
52 Week Low 56.81
Average Volume 6,148,790
200-Day Moving Average 68.9753
50-Day Moving Average 74.2452
20-Day Moving Average 77.9265
10-Day Moving Average 78.567
Average True Range 1.218
ADX 29.64
+DI 31.1771
-DI 16.2205
Chandelier Exit (Long, 3 ATRs ) 76.77600000000001
Chandelier Exit (Short, 3 ATRs ) 78.25399999999999
Upper Bollinger Band 80.4779
Lower Bollinger Band 75.3751
Percent B (%b) 0.89
BandWidth 6.548222
MACD Line 1.4853
MACD Signal Line 1.4635
MACD Histogram 0.0218
Fundamentals Value
Market Cap 138.89 Billion
Num Shares 1.74 Billion
EPS 0.71
Price-to-Earnings (P/E) Ratio 112.59
Price-to-Sales 4.08
Price-to-Book 3.05
PEG Ratio 1.87
Dividend 1.06
Dividend Yield 1.33%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.92
Resistance 3 (R3) 81.86 81.15 81.59
Resistance 2 (R2) 81.15 80.64 81.18 81.48
Resistance 1 (R1) 80.54 80.33 80.85 80.60 81.37
Pivot Point 79.83 79.83 79.98 79.86 79.83
Support 1 (S1) 79.22 79.32 79.53 79.28 78.51
Support 2 (S2) 78.51 79.01 78.54 78.40
Support 3 (S3) 77.90 78.51 78.29
Support 4 (S4) 77.96